- Companies
- The EVERY Company
The EVERY Company Valuation, Funding & Investors
The EVERY Company is valued at $586M as of December 2021.
Last The EVERY Company valuation
$586M
Series C · Dec 2021
Last The EVERY Company funding round
$55M
Series D · Nov 2025
Cumulative funding The EVERY Company raised
$295M
across 6 funding rounds
Key investors in The EVERY Company
SOSV
Grosvenor Food & AgTech
B37 Ventures
McWin Partners
Temasek
IndieBio
About The EVERY Company
San Francisco-based The EVERY Company is a precision fermentation producer of animal-free egg proteins. Founded in 2014, it ferments OvoVitellins, OvoYolk, and OvoAlbumins matching whole egg functionality for baking, dressings, and beverages. EVERY supplies NeatEgg to bakeries for meringues and custards, scaling to 1,000 tons yearly from its South San Francisco facility, partnering with food giants like Mars and Just.
Founded
2015
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Product sales
Valuation
$586M (Dec 2021)
The EVERY Company Valuation
The EVERY Company is currently valued at $586M, based on its Series C in December 2021.
The $175M round was led by McWin Partners and Rage Capital, with participation from Temasek, VamosVentures, Essential Capital, Grosvenor Food & AgTech, Victor Douce and 3 other investors.
The EVERY Company valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Dec 2021 | Series C | $586M |
The EVERY Company Funding History
The EVERY Company has raised a total of $295M across 6 funding rounds.
The EVERY Company's first fundraising round was a $2M seed round in July 2015. The most recent completed round was a $55M Series D in November 2025.
The EVERY Company funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Nov 2025 | Series D | McWin Partners (lead); New Agrarian; Main Sequence Ventures; TO Ventures; Bloom8; Grosvenor Food & AgTech; SOSV; Minerva Foods | $55M | - | The EVERY Company, a San Francisco-based biotechnology firm founded by Arturo Elizondo, pioneered precision fermentation technology to manufacture egg proteins using microbes rather than conventional chickens. The company's OvoPro egg protein ingredient is used by food and beverage manufacturers to create functional products with egg protein characteristics while avoiding animal agriculture. The EVERY Company closed its Series D funding round in November 2025 at $55 million, led by McWin Capital Partners through the McWin Food Tech Fund, with participation from Main Sequence, Bloom8, TO.VC, Minerva Foods, Grosvenor Food & AgTech, New Agrarian, SOSV, and additional investors. The round was the first close of a larger fundraise, with CEO Elizondo indicating a second close was planned later in 2025. The capital is earmarked for manufacturing expansion, movement toward profitability, and broader market penetration in the $270 billion global egg market, particularly targeting the high-volume bakery segment. As of November 2025, The EVERY Company had achieved significant commercial traction, selling metric tons of products at scale to major food manufacturers and rolling out products at Walmart stores nationwide. The cumulative funding raised by the company reached $288 million to $294 million by the time of the Series D announcement. |
| Dec 2021 | Series C | McWin Partners (lead); Rage Capital (lead); Temasek; VamosVentures; Essential Capital; Grosvenor Food & AgTech; Victor Douce; SOSV; The Brkfst Club; Prosus Ventures | $175M | $586M | The EVERY Company, formerly Clara Foods, is a San Francisco-based food technology firm specializing in precision fermentation to produce animal-free functional proteins, particularly egg proteins like ovalbumin (OvoPro) and high-solubility proteins (OvoBoost), targeting the $270 billion egg market for applications in bakery, beverages, and more. The company aims to create a secure global food system by supplying B2B egg protein ingredients that match animal-derived functionality without relying on livestock. In December 2021, it closed an oversubscribed $175 million Series C funding round co-led by McWin Partners and Rage Capital, with participation from investors including Prosus Ventures, Temasek Holdings, SOSV, Grosvenor Food & AgTech, VamosVentures (via TO Ventures), and others, bringing cumulative funding to $233 million at the time. The Series C round, dated around 12/07/2021, valued the company at a post-money valuation of $585.54 million, with a reported price per share of $13.66. Proceeds were earmarked for aggressive expansion of its animal-free protein platform, including scaling manufacturing (with overseas production already underway), commercial sales in the US, Europe, and Asia, partnerships with major food companies like two of the world's largest to de-risk execution, and exploring additional animal proteins beyond eggs such as pepsin. At that stage, the company had de-risked key milestones: proving commercial-scale manufacturing, FDA approval for ingredients, and initial sales traction, positioning it as a plug-and-play platform compatible with large-scale fermentation operations. Investors highlighted the company's transition from proof-of-concept to commercial reality, with CEO Arturo Elizondo noting the capital would enable dominance in animal-free proteins. Later 2025 updates indicate the company had progressed to selling metric tons at scale to major food firms by its Series D. The firm continued raising capital, including a $55 million Series D in late 2025 led by McWin Capital Partners (bringing total funding over $290 million), to further expand US manufacturing, achieve profitability, and launch products nationwide including at Walmart. |
| Nov 2021 | Series A | Agronomics (lead) | $8M | - | - |
| Apr 2019 | Series B | Ingredion (lead); Rich Products Ventures; IndieBio; Veronorte; B37 Ventures; Beyond Impact; SOSV; Hemisphere Ventures; Blue Horizon Corporation | $40M | - | The EVERY Company (formerly Clara Foods) is a biotechnology company that develops animal-free proteins and ingredients using precision fermentation technology. The company specializes in creating functional proteins that replicate the performance of conventional eggs without relying on animal agriculture, with a focus on reducing reliance on volatile egg supply chains affected by avian flu and feed costs. In December 2021, the company closed a Series C round of $175 million co-led by McWin Capital and Rage Capital, with participation from Temasek, Grosvenor's Wheatsheaf Group, TO Ventures, and Prosus Ventures, bringing total funding to $233 million at that time. By November 2025, the company had announced a Series D funding round of $55 million led by McWin Capital Partners, which brought cumulative funding to $294 million. This latest round included investors such as Main Sequence, Bloom8, TO.VC, Minerva Foods, Grosvenor Food & AgTech, New Agrarian, and SOSV. The company has achieved significant commercial traction, with its precision-fermented egg protein ingredients already being integrated into retail products nationwide, including a major rollout in Walmart stores across the United States. The company has demonstrated a clear path to profitability and is targeting the $270 billion global egg market, with particular focus on high-volume applications such as bakery products. |
| Jul 2016 | Series A | B37 Ventures (lead); Benjamin Happ; Twynam Agricultural Group | $15M | - | - |
| Jul 2015 | Seed | Scott Banister; Hadi Partovi; Mission and Market; David Friedberg; SOSV; Gary Hirshberg; UpHonest Capital; Ali Partovi | $2M | - | - |
Who has invested in The EVERY Company?
33 investors have backed The EVERY Company across its funding rounds, including SOSV, Grosvenor Food & AgTech, B37 Ventures, McWin Partners, Temasek and IndieBio.
Lead investors include McWin Partners, Rage Capital, Agronomics, Ingredion and B37 Ventures.
The EVERY Company Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 4 | Participant | Jul 2015 | ||
| 2 | Lead | Jul 2016 | ||
| 2 | Lead | Dec 2021 | ||
| 2 | Participant | Dec 2021 | ||
| 1 | Participant | Dec 2021 | ||
| 1 | Participant | Nov 2025 | ||
| 1 | Participant | Apr 2019 | ||
| 1 | Participant | Jul 2015 | ||
| 1 | Participant | Apr 2019 | ||
| 1 | Participant | Dec 2021 | ||
| 1 | Participant | Apr 2019 | ||
| 1 | Participant | Nov 2025 | ||
| 1 | Lead | Dec 2021 | ||
This data is available for Pro users. Sign up to see all 33 The EVERY Company investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialThe EVERY Company Competitors
The EVERY Company competitors include listed companies like Anhui Huaheng, Gujarat State Fertilizers and Grupa Azoty, and private ones like Meati, Believer Meats and Remilk.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $650M | - | ||
| Private | - | - | $900M | - | ||
| Private | - | - | $325M | - | ||
| Publicly listed | $427M | $56M | $622M | 2.0x | ||
| Publicly listed | $1.1B | $97M | $633M | 0.4x | ||
| Publicly listed | $3.5B | ($865M) | $532M | 0.9x |
The EVERY Company Public Comps
The EVERY Company is still privately-owned, but its public comps include Modern Mills, Lesieur Cristal, Cem Zeytin, Fourth Milling, Nichols, ForFarmers, Mama's Creations, SunRice, Anhui Huaheng and Rogers Sugar.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $279M | $85M | 2.8x | 2.6x | 9.2x | 8.8x | |||
| $582M | $24M | 0.9x | 0.9x | 22.7x | 18.3x | |||
| $58M | ($3M) | 10.5x | - | (232.3x) | - | |||
| $176M | $72M | 3.4x | 3.4x | 8.5x | 8.5x | |||
| $235M | $40M | 2.0x | 1.9x | 12.0x | 9.7x | |||
| $3.6B | $158M | 0.2x | 0.2x | 5.1x | 4.6x | |||
| $172M | $12M | 2.9x | 2.4x | 41.0x | 24.3x | |||
| $1.3B | $101M | 0.6x | 0.6x | 7.4x | 8.0x | |||
This data is available for Pro users. Sign up to see all The EVERY Company competitors and their valuation data. Start Free Trial | ||||||||
Common questions about The EVERY Company
| When was The EVERY Company founded? | The EVERY Company was founded in 2015. |
| Where is The EVERY Company headquartered? | The EVERY Company is headquartered in San Francisco, CA, United States. |
| Is The EVERY Company publicly listed? | No, The EVERY Company is a private, VC-backed company. |
| What is The EVERY Company's valuation? | The EVERY Company was last valued at $586M in its Series C in December 2021. |
| How much funding has The EVERY Company raised? | The EVERY Company has raised $295M across 6 funding rounds. |
| What was The EVERY Company's last funding round? | The EVERY Company's last funding round was a $55M Series D in November 2025, led by McWin Partners. |
| Who are The EVERY Company's investors? | The EVERY Company's investors include SOSV, B37 Ventures, McWin Partners, Grosvenor Food & AgTech, Temasek, New Agrarian, Rich Products Ventures, Scott Banister, IndieBio, VamosVentures and 23 others. |
| Which companies are comparable to The EVERY Company? | Companies comparable to The EVERY Company include Meati, Believer Meats, Remilk, Anhui Huaheng, Gujarat State Fertilizers and Grupa Azoty. |
See companies similar to The EVERY Company
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




